Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Protein secretion Sec translocation machinery is a highly conserved protein complex that mediates the export of unfolded polypeptides across cellular or organellar membranes. In bacteria, it consists primarily of the SecYEG channel and the SecA ATPase motor, which threads proteins through a membrane pore using ATP hydrolysis and the proton gradient as energy sources. Precursor proteins are directed to the complex by N-terminal signal sequences, kept unfolded by chaperones (such as SecB), and translocated through SecYEG (bacteria) or Sec61 (eukaryotes), either post-translationally or co-translationally. This machinery is essential for bacterial viability and the secretion of pathogenic factors, representing an attractive target for new classes of antibiotics.
Inhibition of SecA ATPase activity (blocks energy-dependent translocation); Disruption of SecYEG complex function (prevents protein export and cell wall protein localization)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein secretion Sec translocation machinery (Sec machinery (SecYEG complex in bacteria; Sec61 complex in eukaryotes)).